SCHEMBL625197

SCHEMBL625197

O=C(Nc1ncc(F)s1)C(OC1CCCC1)c1ccc(S(=O)(=O)C2CCOCC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625210 0.99 GCK (0.70) GCK
SCHEMBL184634 0.95 GCK (0.77) GCK
SCHEMBL184491 0.87 GCK (0.63) GCK
SCHEMBL11972156 0.86 GCK (0.66) GCK
SCHEMBL625462 0.84 GCK (0.67) GCK
SCHEMBL185076 0.84 GCK (0.73) GCK
SCHEMBL623314 0.83 GCK (0.66) GCK
SCHEMBL2657290 0.83 GCK (0.64) GCK
SCHEMBL185118 0.83 GCK (0.90) GCK
SCHEMBL185059 0.83 GCK (1.00) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO claimed
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO disclosed